Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xoc Pharmaceuticals

Xoc Pharmaceuticals?uq=K9LEA9hy
2013 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$30M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of neurological therapeutics and delivery technologies designed to increase the efficacy, safety and side effect profiles of known compounds. The company's therapeutic pharmaceutical development strategy combines targeted molecular modification and optimized route delivery, enabling neurology patients to experience greater results from established therapies.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 15732 Los Gatos Boulevard
  • #326
  • Los Gatos, CA 95032
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xoc Pharmaceuticals’s full profile, request a free trial.

Xoc Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 06-Feb-2018 $30M 0000 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Xoc Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A-2 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-1 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table, request access »

Xoc Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
New Enterprise Associates Venture Capital Minority 000 0000 000000 0

Xoc Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Scott Borland Chief Executive Officer, President & Board Member

Xoc Pharmaceuticals Board Members (4)

Name Representing Role Since Contact
Info
Frank Torti MD New Enterprise Associates Board Member 000 0000
Scott Borland Xoc Pharmaceuticals Chief Executive Officer, President & Board Member 000 0000
Thomas Armer Ph.D Self Board Member 000 0000
Timothy Nelson Self Board Member 000 0000